Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from NKGen Biotech ( (NKGN) ) is now available.
NKGen Biotech has announced a delay in filing its quarterly report due to the complex valuation of derivative securities, leading to a notice from Nasdaq for non-compliance with filing rules. Despite this, the company’s stock remains unaffected and it has been granted a temporary exception until January 2025, during which it plans to resolve these issues and potentially acquire a majority interest in NKMax Co. Ltd. Investors should be aware of the potential risks and uncertainties related to these developments.
See more data about NKGN stock on TipRanks’ Stock Analysis page.